Avascular Necrosis Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028

Status : Ongoing | Report Code : FACT3146MR

Avascular necrosis is a condition in which bone tissue dies due to reduced blood flow to bones. Avascular necrosis also is known as osteonecrosis, bone necrosis, aseptic necrosis, and ischemic bone necrosis. Avascular necrosis commonly occurs in body sites such as hip, shoulder, ankle, and knees. Avascular necrosis is basically two type’s traumatic avascular necrosis and non-traumatic avascular necrosis. Avascular necrosis can be the result as reduction of blood supply due to fracture and dislocation of bone, excessive use of chronic corticosteroids and alcohol. Other conditions associated with non-traumatic avascular necrosis are sickle cell disease, metabolic bone disorders such as Gaucher disease etc. Therapeutic treatment and surgical treatment are available to treat avascular necrosis. Surgical treatment procedures such as bone grafting, osteotomy, total joint replacement, core decompression, vascularized bone graft placement are performed to treat avascular necrosis. Therapeutic treatment such as nonsteroidal anti-inflammatory drugs (NSAIDS), osteoporosis drugs, cholesterol-lowing drugs, blood thinners are prescribed to treat avascular necrosis.

Growing number of road accidents and traumatic injuries expected propel the growth of the avascular necrosis market over the forecast period. Increasing consumption of alcohol and excessive intake of corticosteroids expected to favors the growth of the avascular necrosis market. Growing adoption of advanced minimally-invasive surgical treatment expected to boost the growth of avascular necrosis market. Increasing research and development activities for drug development expected to upsurge avascular necrosis market growth opportunity near the future. However, the shortage of skilled orthopedic surgeons expected to restrain the growth of the avascular necrosis market. Moreover, less awareness among people regarding disease and strict regulatory requirement are expected to hamper the growth of avascular necrosis market.

The global Avascular Necrosis market is segmented on basis of disease type, treatment type, distribution sales and region:

  • Segmentation by Disease Type
  • Traumatic Avascular Necrosis
  • Non-traumatic Avascular Necrosis
  • Segmentation by Treatment Type
  • Therapeutic Treatment
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
    • Osteoporosis Drugs
    • Cholesterol Lowing Drugs
    • Blood Thinners
  • Surgical Treatment
    • Bone Grafting
    • Osteotomy
    • Total Joint Replacement
    • Core Decompression
    • Vascularized Bone Graft Placement
  • Segmentation by Sales Channel
  • Retail Sales
    • Hospital Pharmacies
    • Retail Pharmacies
    • Drug Store
  • Institutional Sales
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Orthopedic Clinics

For more insights, request sample of this report.

Avascular Necrosis market expected to represent a significant growth rate over the forecast period. Non-traumatic avascular necrosis segment expected to gain high share in avascular necrosis market owing to increased alcohol consumption, metabolic bone disorders, and other disorder. Based on treatment type, surgical treatment segment expected to expand at a faster rate and gain maximum share in the market. Surgical treatment options such as bone grafting are expected to grow with significant growth rate as increasing adoption of minimally invasive surgeries.

Regionally, the global Avascular Necrosis market is segmented into five key regions viz. North America, Latin America, Europe, Middle East & Africa and Asia Pacific. North America is expected to contribute major revenue share in the global avascular necrosis market owing to high adoption advanced treatment option and the higher concentration of market players. Europe also shows the high growth rate in the avascular necrosis market due to the increasing number of surgical procedures and drug development. Avascular necrosis market in the Asia-Pacific region is expected to witness significant growth rate in the coming years due to increasing healthcare expenditure and higher prevalence of bone disorders in countries such as India & China.

Some of the players operating in the global Avascular Necrosis market are Wright Medical Group Inc., Medtronic Plc., Zimmer Biomet, Sanofi SA, Pfizer Inc., Merck KGaA, Integra LifeSciences Corporation, Eli Lilly & Company, Arthrex Inc., Smith & Nephew Plc., Stryker Corporation, Johnson & Johnson, Bayer AG, Baxter International, Berkeley Advanced Biomaterials, Inc. and others.

The report covers exhaustive analysis on:

  • Avascular Necrosis Market Segments
  • Avascular Necrosis Market Dynamics
  • Historical Actual Market Size, 2013 - 2017
  • Avascular Necrosis Market Size & Forecast 2018 to 2026
  • Avascular Necrosis Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Avascular Necrosis Market Drivers and Restraints

Regional Analysis:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

For more insights, request sample of this report.

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Avascular Necrosis Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028